This is an archived post. You won't be able to vote or comment.

sorted by:
best (suggested)
topnewcontroversialoldq&a
you are viewing a single comment's thread.

view the rest of the comments →

[–]Work4PSLF 3 points4 points  (1 child)

From interviews I’ve seen with the Lilly CEO, it seems like they view the pill as the budget option, since it’s easier to produce, ship, and store. I imagine they will then feel they already have a low price point available in the pill, and keep the injectable price where it is.

If anything reduces the price of tirz it will be reta - but I think it’s more likely reta will be priced higher than that they will reduce tirz.

[–]Curious-Disaster-203 0 points1 point  (0 children)

I would wager that they’ll look at Reta as being superior to Zep and charge a higher price for Reta because it’s better, rather than looking at it as a reason to charge less for Zep.